Infectious Disease Care
CUUR DIAGNOSTICS
Omicron Variant
CUUR Diagnostics
Topic: COVID-19 Omicron Variant
What the CDC Is Saying:

Omicron Variant

On Tuesday, November 30, 2021, the U.S. government SARS-CoV-2 Interagency Group made the decision to classify the Omicron variant as a Variant of Concern (VOC). This decision is based on multiple factors, including the detection of Omicron cases in multiple countries, transmission and displacement of Delta in South Africa, and mutations in the virus that could indicate a reduction in the effectiveness of COVID-19 vaccines and certain monoclonal antibody treatments. No cases of this variant have been identified in the U.S. to date. CDC is following the details of this new variant. Link.

Vaccines 

  • FDA approved or authorized COVID-19 vaccines protect against Delta and other known variants.
  • Vaccines reduce your risk of severe illness, hospitalization, and death from COVID-19.
  • We don’t yet know how effective the vaccines will be against new variants that may arise.
 

Symptoms 

  • All variants cause similar COVID-19 symptoms.
  • Some variants, such as the Alpha and Delta variants, may cause more severe illness and death.

Types of Variants

Scientists monitor all variants but may classify certain ones as Variants Being Monitored, Variants of Concern, Variants of Interest or Variants of High Consequence. Some variants seem to spread more easily and quickly than other variants, which may lead to more cases of COVID-19. An increase in the number of cases will put more strain on healthcare resources, lead to more hospitalizations, and potentially more deaths.

These classifications are based on how easily the variant spreads, how severe the symptoms are, how the variant responds to treatments, or how well vaccines protect against the variant.

Infectious Disease Care
Infectious Disease Care

CUUR Diagnostics is a biotechnology company focused on improving patient, provider and facility healthcare outcomes for Infectious Disease. Learn More.

CuurBox
CUUR BOX

Ask your physician for the CUUR Box. The easy 1,2,3 of sample testing – Swap, Pack, Ship. Over 97% of tests returned in 24-48 of hours from receipt. Learn More.

CuurCloud
CuurCloud

CuurCloud is a robust laboratory information management system and provider/patient portal that supports the infectious disease diagnostics efforts of CUUR Diagnostics and its customers. Learn More.

Infectious Disease Care
Learn More Important Information About CUUR Diagnostics by Visiting Our Main Site.

CUUR Diagnostics was founded by experienced medical scientists and healthcare professionals and utilize industry leading equipment including Thermofisher, under CAP and CLIA quality standards, to rapidly deliver high complexity qPCR molecular testing for infectious disease identification. The CUUR Diagnostics’ SARS-COV-2 assay is an Emergency Use Authorization (EUA) test awarded by the U.S. FDA.

CUUR Diagnostics is a division of Assurity Healthcare, a Medicare-certified clinical laboratory provider that offers innovative healthcare laboratory solutions to hospitals, clinics and other medical entities. Serving clients across multiple states in the U.S., our services include infectious disease testing, planning, build-out, staffing, compliance and operation of complex medical labs.

CUUR Panels:
Respiratory w/COVID-19, UTI, Skin & Wound, Vaginal Microbiota, Nail, STI, Gastrointestinal, Antimicrobial Resistance, and Custom Panels

.

Stay in Touch

Don’t Miss A Beat! Learn Valuable Viewpoints About Today’s Infectious Disease Issues